Renaissance Technologies (RenTech)'s RPRX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 1.94 M shares of Royalty Pharma plc (RPRX) worth $108.54 M, representing 0.15% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in RPRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 1.14 M shares. Largest reduction occurred in Q1 2022, reducing 615,200 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Royalty Pharma plc (RPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Royalty Pharma plc (RPRX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +1.14 M | Add 144.75% | 1.94 M | $56.07 |
| Q1 2026 | +790,937 | New Buy | 790,937 | $47.97 |
| Q2 2024 | -10,190 | Sold Out | 0 | $0.00 |
| Q1 2024 | +10,190 | New Buy | 10,190 | $30.32 |
| Q4 2023 | -483,200 | Sold Out | 0 | $0.00 |
| Q3 2023 | -287,500 | Reduce 37.30% | 483,200 | $27.14 |
| Q2 2023 | -530,200 | Reduce 40.76% | 770,700 | $0.03 |
| Q1 2023 | +431,900 | Add 49.70% | 1.3 M | $0.04 |
| Q4 2022 | +869,000 | New Buy | 869,000 | $0.04 |
| Q2 2022 | -183,900 | Sold Out | 0 | $0.00 |
| Q1 2022 | -615,200 | Reduce 76.99% | 183,900 | $38.96 |
| Q4 2021 | +15,500 | Add 1.98% | 799,100 | $39.85 |
| Q3 2021 | -45,000 | Reduce 5.43% | 783,600 | $36.14 |
| Q2 2021 | +828,600 | New Buy | 828,600 | $40.99 |
Renaissance Technologies (RenTech)'s Royalty Pharma plc Investment FAQs
Renaissance Technologies (RenTech) first purchased Royalty Pharma plc (RPRX) in Q2 2021, acquiring 828,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Royalty Pharma plc (RPRX) for 14 quarters since Q2 2021.
Renaissance Technologies (RenTech)'s largest addition to Royalty Pharma plc (RPRX) was in Q2 2026, adding 1,935,800 shares worth $108.54 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 1,935,800 shares of Royalty Pharma plc (RPRX), valued at approximately $108.54 M.
As of the Q2 2026 filing, Royalty Pharma plc (RPRX) represents approximately 0.15% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Royalty Pharma plc (RPRX) was 1,935,800 shares, as reported at the end of Q2 2026.